Felgner S - Search Results

1

Characterization of Novel Factors Involved in Swimming and Swarming Motility in Salmonella enterica Serovar Typhimurium.

Deditius JA, Felgner S, Spöring I, Kühne C, Frahm M, Rohde M, Weiß S, Erhardt M. Deditius JA, et al. Among authors: felgner s. PLoS One. 2015 Aug 12;10(8):e0135351. doi: 10.1371/journal.pone.0135351. eCollection 2015. PLoS One. 2015. PMID: 26267246 Free PMC article.

2

Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy.

Frahm M, Felgner S, Kocijancic D, Rohde M, Hensel M, Curtiss R 3rd, Erhardt M, Weiss S. Frahm M, et al. Among authors: felgner s. mBio. 2015 Apr 14;6(2):e00254-15. doi: 10.1128/mBio.00254-15. mBio. 2015. PMID: 25873375 Free PMC article.

3

Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy.

Felgner S, Kocijancic D, Frahm M, Curtiss R 3rd, Erhardt M, Weiss S. Felgner S, et al. Gut Microbes. 2016;7(2):171-7. doi: 10.1080/19490976.2016.1155021. Gut Microbes. 2016. PMID: 26939530 Free PMC article. Review.

4

The immunogenic potential of bacterial flagella for Salmonella-mediated tumor therapy.

Felgner S, Spöring I, Pawar V, Kocijancic D, Preusse M, Falk C, Rohde M, Häussler S, Weiss S, Erhardt M. Felgner S, et al. Int J Cancer. 2020 Jul 15;147(2):448-460. doi: 10.1002/ijc.32807. Epub 2020 Jan 7. Int J Cancer. 2020. PMID: 31755108

5

aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant.

Felgner S, Frahm M, Kocijancic D, Rohde M, Eckweiler D, Bielecka A, Bueno E, Cava F, Abraham WR, Curtiss R 3rd, Häussler S, Erhardt M, Weiss S. Felgner S, et al. mBio. 2016 Sep 6;7(5):e01220-16. doi: 10.1128/mBio.01220-16. mBio. 2016. PMID: 27601574 Free PMC article.

6

Regulation of Flagellum Biosynthesis in Response to Cell Envelope Stress in Salmonella enterica Serovar Typhimurium.

Spöring I, Felgner S, Preuße M, Eckweiler D, Rohde M, Häussler S, Weiss S, Erhardt M. Spöring I, et al. Among authors: felgner s. mBio. 2018 May 1;9(3):e00736-17. doi: 10.1128/mBio.00736-17. mBio. 2018. PMID: 29717015 Free PMC article.

7

Biomimetic Salmonella: A Next-Generation Therapeutic Vector?

Felgner S, Kocijancic D, Pawar V, Weiss S. Felgner S, et al. Trends Microbiol. 2016 Nov;24(11):850-852. doi: 10.1016/j.tim.2016.08.007. Epub 2016 Sep 7. Trends Microbiol. 2016. PMID: 27614692

8

Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.

Kocijancic D, Felgner S, Schauer T, Frahm M, Heise U, Zimmermann K, Erhardt M, Weiss S. Kocijancic D, et al. Among authors: felgner s. Oncotarget. 2017 Jul 25;8(30):49988-50001. doi: 10.18632/oncotarget.18392. Oncotarget. 2017. PMID: 28637010 Free PMC article.

9

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

Felgner S, Kocijancic D, Frahm M, Heise U, Rohde M, Zimmermann K, Falk C, Erhardt M, Weiss S. Felgner S, et al. Oncoimmunology. 2017 Oct 16;7(2):e1382791. doi: 10.1080/2162402X.2017.1382791. eCollection 2018. Oncoimmunology. 2017. PMID: 29308303 Free PMC article.

10

Bacteria in Cancer Therapy: Renaissance of an Old Concept.

Felgner S, Kocijancic D, Frahm M, Weiss S. Felgner S, et al. Int J Microbiol. 2016;2016:8451728. doi: 10.1155/2016/8451728. Epub 2016 Mar 8. Int J Microbiol. 2016. PMID: 27051423 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters